Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$14.88 and traded as low as C$14.35. Cipher Pharmaceuticals shares last traded at C$14.44, with a volume of 39,207 shares changing hands.
Cipher Pharmaceuticals Price Performance
The company has a market cap of C$428.75 million, a price-to-earnings ratio of 25.22 and a beta of 1.33. The company has a 50-day simple moving average of C$14.90 and a 200-day simple moving average of C$14.94. The company has a debt-to-equity ratio of 11.75, a quick ratio of 2.67 and a current ratio of 1.30.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
